Aarsland, D <br/><br/>
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  Jun 2002 
 - 708-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3050 
<br/><br/><label>Standard No.: </label>10.1136/jnnp.72.6.708  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Cholinesterase Inhibitors--administration & dosage<br/>Cognition Disorders--drug therapy<br/>Cross-Over Studies<br/>Donepezil<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Indans--administration & dosage<br/>Male<br/>Mental Status Schedule<br/>Middle Aged<br/>Parkinson Disease--complications<br/>Piperidines--administration & dosage<br/>Treatment Outcome